ALK and prostate adenocarcinoma: Small Cell Transformation of Metachronous ALK + ve Lung and Prostatic Adenocarcinoma following Initial Response to Ceritinib and Androgen Deprivation Therapies and Metastases to Two Different Organs: Guidance through FDG-PET/CT and &lt;sup&gt;68&lt;/sup&gt; Ga-PSMA-11 PET-CT and Biopsy-Immunohistochemistry Correlation.